80 related articles for article (PubMed ID: 11705861)
41. A semiautomated test for microsatellite instability and its significance for the prognosis of sporadic endometrial cancer in northern Norway.
Ørbo A; Eklo K; Kopp M
Int J Gynecol Pathol; 2002 Jan; 21(1):27-33. PubMed ID: 11781520
[TBL] [Abstract][Full Text] [Related]
42. Low frequency of microsatellite instability in hereditary prostate cancer.
Ahman AK; Jonsson BA; Damber JE; Bergh A; Grönberg H
BJU Int; 2001 Mar; 87(4):334-8. PubMed ID: 11251526
[TBL] [Abstract][Full Text] [Related]
43. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma.
Schäffler A; Palitzsch KD; Seiffarth C; Höhne HM; Riedhammer FJ; Hofstädter F; Schölmerich J; Rüschoff J
Eur J Clin Invest; 1998 Oct; 28(10):838-44. PubMed ID: 9792998
[TBL] [Abstract][Full Text] [Related]
44. Patient survival and microsatellite instability in gliomas by high-resolution fluorescent analysis.
Mizoguchi M; Inamura T; Ikezaki K; Iwaki T; Oda S; Maehara Y; Oki E; Terasaki M; Fukui M
Oncol Rep; 1999; 6(4):791-5. PubMed ID: 10373658
[TBL] [Abstract][Full Text] [Related]
45. Frequent microsatellite alterations in a predominantly younger age of onset breast cancer population.
Luqmani YA; Mathew M; Lobo S
Int J Mol Med; 2003 Jan; 11(1):117-24. PubMed ID: 12469230
[TBL] [Abstract][Full Text] [Related]
46. Allelic variation of BAT-25 and BAT-26 mononucleotide repeat loci in tumours from a group of young women with breast cancer.
Luqmani YA; Mathew M
Int J Oncol; 2004 Sep; 25(3):771-5. PubMed ID: 15289882
[TBL] [Abstract][Full Text] [Related]
47. [Microsatellite instability in nephroblastoma and its relationship to clinicopathological variables].
Shen Z; He Z; Bu X
Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):207-10. PubMed ID: 10072864
[TBL] [Abstract][Full Text] [Related]
48. Microsatellite DNA instability in COPD.
Siafakas NM; Tzortzaki EG; Sourvinos G; Bouros D; Tzanakis N; Kafatos A; Spandidos D
Chest; 1999 Jul; 116(1):47-51. PubMed ID: 10424502
[TBL] [Abstract][Full Text] [Related]
49. [Various parameters of cellular mass metabolism in highly differentiated thyroid cancer].
Sznapka Z
Pol Przegl Chir; 1980 Aug; 52(8):665-8. PubMed ID: 7433273
[No Abstract] [Full Text] [Related]
50. Microsatellite instability (MSI) markers in thyroid carcinoma.
Mastronikolis N; Chrysovergis A; Tsiambas E; Kyrodimos E
J BUON; 2021; 26(3):1169. PubMed ID: 34268987
[No Abstract] [Full Text] [Related]
51. [Several hot issues on thyroid cancer basic research].
Yin D; Xu J
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):885-7. PubMed ID: 26081047
[No Abstract] [Full Text] [Related]
52. Microsatellite instability in benign and malignant thyroid neoplasms.
Mitmaker E; Alvarado C; Bégin LR; Trifiro M
J Surg Res; 2008 Nov; 150(1):40-8. PubMed ID: 18243241
[TBL] [Abstract][Full Text] [Related]
53. Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane.
Gulwani D; Upadhyay P; Goel R; Sarangthem V; Debraj Singh T
Asian Pac J Cancer Prev; 2023 Feb; 24(2):375-387. PubMed ID: 36853284
[TBL] [Abstract][Full Text] [Related]
54. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
[TBL] [Abstract][Full Text] [Related]
55. Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.
Moon C; Gordon M; Moon D; Reynolds T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884669
[TBL] [Abstract][Full Text] [Related]
56. Co-Occurrence of Differentiated Thyroid Cancer and Second Primary Malignancy: Correlation with Expression Profiles of Mismatch Repair Protein and Cell Cycle Regulators.
Liu CY; Huang CS; Huang CC; Ku WC; Shih HY; Huang CJ
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771648
[TBL] [Abstract][Full Text] [Related]
57. The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma - systematic review and discussion of current therapeutic options.
Rocha ML; Schmid KW; Czapiewski P
Contemp Oncol (Pozn); 2021; 25(3):213-223. PubMed ID: 34729042
[TBL] [Abstract][Full Text] [Related]
58. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Genutis LK; Tomsic J; Bundschuh RA; Brock PL; Williams MD; Roychowdhury S; Reeser JW; Frankel WL; Alsomali M; Routbort MJ; Broaddus RR; Wakely PE; Phay JE; Walker CJ; de la Chapelle A
Thyroid; 2019 Apr; 29(4):523-529. PubMed ID: 30747051
[TBL] [Abstract][Full Text] [Related]
59. Classification and characterization of microsatellite instability across 18 cancer types.
Hause RJ; Pritchard CC; Shendure J; Salipante SJ
Nat Med; 2016 Nov; 22(11):1342-1350. PubMed ID: 27694933
[TBL] [Abstract][Full Text] [Related]
60. The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.
Grogan RH; Mitmaker EJ; Clark OH
Cancers (Basel); 2010 May; 2(2):885-912. PubMed ID: 24281099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
